The anemia in continuous ambulatory peritoneal dialysis patients is related to Kt/V index

Artificial Organs

Volumn 23, Issue 1, 1999, Pages 65-69

  Opatrný Jr , Karel ^a,b   Opatrná, Sylvie ^a   Šefrna, František ^a   Wirth, Jan ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b First Dept of Internal Medicine   (Czech Republic)

Author keywords

Adequacy; Anemia; Chronic renal failure; Continuous ambulatory peritoneal dialysis

Indexed keywords

BLOOD; DIALYSIS; PURIFICATION;

ADEQUACY; ANEMIA; BLOOD PURIFICATION; CHRONIC RENAL FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; GLOMERULAR FILTRATION RATE; HAEMATOCRIT; PERITONEAL DIALYSIS; RENAL FUNCTIONS; STEPWISE REGRESSION ANALYSIS;

REGRESSION ANALYSIS;

ALBUMIN; CREATININE; TRANSFERRIN; UREA;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HEMATOCRIT; HUMAN; MALE; PRIORITY JOURNAL; PURIFICATION; REGRESSION ANALYSIS;

GLOMERULUS;

EID: 0032908040     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1999.06221.x     Document Type: Article

References (35)

1. Kokot F, Wiecek A. Evidence that the anemia of renal failure participates in overall uremic toxicity. Kidney Int 1997;Suppl. 62:83-6.
2. Madore F, Lowrie EG, Brugnara C, Lew NL, Lazarus JM, Bridges K, Owen WF. Anemia in hemodialysis patients: Variables affecting this outcome predictor. J Am Soc Nephrol 1997;8:1921-9.
3. Rademacher J, Koch KM. Treatment of renal anemia by erythropoietin substitution. The effects on the cardiovascular system. Clin Nephrol 1995;44(Suppl):56-60.
4. Valderrabano F. Erythropoietin in chronic renal failure. Kidney Int 1996;50:1373-91.
5. Nissenson AR. Recombinant human erythropoietin: Impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life. Semin Nephrol 1989;9(Suppl. 2):25-31.
6. Meierhenrich R, Jedicke H, Voigt A, Lange H. The effect of exercise in dialysis patients. Clin Nephrol 1996;45:90-6.
7. Macdougall IC, Hutton D, Cavill I, Coles G, Williams JD. Poor response to treatment of renal anemia with erythropoietin corrected by iron given intravenously. Br Med J 1989;299:157-8.
8. Van Wyck DB, Stivelman JC, Ruiz K, Kirlin LF, Katz MA, Ogden DA. Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int 1989;35:712-6.
9. Muirhead N, Hodsman AB. Occult infection and resistance of anaemia to r-HuEPO therapy in renal failure. Nephrol Dial Transplant 1990;5:232-4.
10. Meytes D, Bogin E, Ma A, Dukes PP, Massry SG. Effect of parathyroid hormone on erythropoiesis. J Clin Invest 1981;67:1263-9.
11. Rao DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 1993;328:171-5.
12. Bia MJ, Cooper K, Schnall S, Duffy T, Hendler E, Malluche H, Solomon L. Aluminum induced anemia: Pathogenesis and treatment in patients on chronic hemodialysis. Kidney Int 1989;36:852-8.
13. Drüeke TB. R-HuEPO hyporesponsiveness - Who and why? Nephrol Dial Transplant 1995;10(Suppl. 2):62-8.
14. Eschbach JW. Hematological problems of renal failure. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF, eds. Replacement of renal function by dialysis. Fourth revised edition. Dordrecht/Boston/London: Kluwer, 1996:1059-76.
15. Ifudu O, Feldman J, Friedman EA. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 1996;334:420-5.
16. Teehan BP, Schleifer CR, Brown JM, Sigler MH, Raimondo J. Urea kinetic analysis and clinical outcome on CAPD. A five year longitudinal study. Adv Perit Dial 1990;6:181-7.
17. Lameire NH, Vanholder R, Veyt D, Lambert M-C, Ringoir S. A longitudinal, five year survey of urea kinetic parameters in CAPD patients. Kidney Int 1992;42:426-32.
18. Tzamaloukas AH, Murata GH, Sena P. When do plasma levels of azotemic indices indicate inadequacy of peritoneal dialysis? Nephron 1994;67:495-6.
19. Opatrná S, Opatrný K Jr, Čejková P, Šefrna F, Hostašová A, Opatrný K. Relationship between anemia and adequacy of continuous ambulatory peritoneal dialysis. Nephron 1997;77:359-60.
20. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from anthropometric measurements. Am J Clin Nutr 1980;33:27-9.
21. Milutinovic J, Cutler RE, Hoover P, Meijsen B, Scribner BH. Measurement of residual glomerular filtration rate in the patient receiving repetitive hemodialysis. Kidney Int 1975;8:185-90.
22. Churchill DN, Thorpe K, Taylor DW, Keshiaviah P for the Canada-USA Study of Peritoneal Dialysis Adequacy. Adequacy of peritoneal dialysis. J Am Soc Nephrol 1994;5:439.
23. Blake PG. Targets on CAPD and APD Prescription. Perit Dial Int 1996;16:(Suppl. 1):143-6.
24. Lameire NH. The impact of residual renal function on the adequacy of peritoneal dialysis. Nephron 1997;77:1:13-28.
25. Harty J, Gokal R. The impact of peritoneal permeability and residual renal function on PD prescription. Perit Dial Int 1996;16(Suppl. 1):147-52.
26. Ifudu O, Friedman EA. Economic implications of inadequate response to erythropoietin in patients with end-stage renal disease. Dial Transplant 1997;10:664-98.
27. Stegeman CA, Kloppenburg WD, Huisman RM, de Jong PE. The erythropoietin dose correlates with dialysis adequacy in patients on chronic hemodialysis. J Am Soc Nephrol 1995;3:563.
28. Wallner SF, Vautrin RM. Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. J Lab Clin Med 1981;97:170-8.
29. Radtke HW, Rege AB, LaMarche MB, Bartos D, Bartos F, Campbell RA, Fisher JW. Identification of spermine as an inhibitor of erythropoiesis in patients with chronic renal failure. J Clin Invest 1981;67:1623-9.
30. Kushner D, Beckman B, Nguyen L, Chen S, Santiana CD, Husserl F, Rice J, Fisher JW. Polyamines in the anemia of end-stage renal disease. Kidney Int 1991;39:725-32.
31. Niwa T, Yazawa T, Kodama T, Uehara Y, Maeda K, Yamada K. Efficient removal of albumin-bound furancarboxylic acid, an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis. Nephron 1990;56:241-5.
32. Joske RA, McAlister JM, Prankerd TAJ. Isotope investigations of red cell production and destruction in chronic renal disease. Clin Sci 1956;15:511.
33. 14Cyanate as a tag for red cell survival in normal and uremic man. J Lab Clin Med 1977; 89:823-8.
34. Gafter U, Malachi T, Barak H, Djaldetti M, Levi J. Red blood cell calcium homeostasis in patients with end-stage renal disease. J Lab Clin Med 1989;114:222-31.
35. Eschbach JW. Erythropoietin 1991 - An overview. Am J Kidney Dis 1991;18(Suppl. 1):3.